Skip to main content
PMC home page
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;6(3):236–241. doi: 10.1111/j.1542-474X.2001.tb00114.x

Value and Limitations of Ambulatory ECG Monitoring for Assessment of Myocardial Ischemia

Dan Tzivoni 1,✉
PMCID: PMC7027627  PMID: 11466143

Abstract

Ambulatory ECG monitoring (AEM) is the only available method to assess the presence and severity of myocardial ischemia during daily life. Several investigators have shown that the recording systems currently used can detect ischemic changes with similar accuracy as treadmill exercise testing. Ischemic changes on AEM are, however, present in only 40%‐60% of patients with coronary artery disease (CAD) and positive exercise tests. For this reason, and because of the high day‐to‐day variability in daily ischemic changes, AEM cannot be used as a screening tool for detecting CAD or for evaluating severity of ischemia in individual patients. In patients with proven CAD, ischemic changes on AEM are associated with an adverse outcome in patients with stable and unstable ischemic syndromes, and in postmyocardial infarction patients. Suppression of daily ischemia seems to be associated with improved outcome. The mechanism of daily ischemia is not identical to exercise‐induced ischemia. In addition to increased demand, which is a major contributor to AEM detected‐ischemia, increased coronary tone also seems to play a major role. AEM has been shown to be a useful and reliable tool to assess the efficacy of various antiischemic drugs. A.N.E. 2001; 6(3):236–242

Keywords: myocardial ischemia, ambulatory ECG monitoring, exercise testing

REFERENCES

  • 1. Gilson JS, Holter NJ, Glassock WR. Clinical observations using the electrocardiocorder AVSEP continuous electro‐cardiographic system: Tentative standard and clinical patterns. Am J Cardiol 1964;12:204–215. [DOI] [PubMed] [Google Scholar]
  • 2. Stern S, Tzivoni D. Early detection of silent ischemic heart disease by 24‐hour electrocardiographic monitoring of active subjects. Br Heart J 1974;36:481–486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Stern S, Tzivoni D, Stern Z. Diagnostic accuracy of ambulatory electrocardiographic monitoring in ischemic heart disease. Circulation 1975;52:1045–1049. [DOI] [PubMed] [Google Scholar]
  • 4. Schang SJ, Pepine CJ. Transient asymptomatic ST segment depression during daily activity. Am J Cardiol 1977;39:396–402. [DOI] [PubMed] [Google Scholar]
  • 5. Deanfield JE, Maseri A, Selwyn AP, et al. Myocardial ischemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 1983;2:753–758. [DOI] [PubMed] [Google Scholar]
  • 6. Deanfield JE, Shea M. Ribiero P, et al. Transient ST segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984;54: 1195–1200. [DOI] [PubMed] [Google Scholar]
  • 7. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. New Engl J Med 1979;300:1350–1358. [DOI] [PubMed] [Google Scholar]
  • 8. Callaham PR, Froelicher VF, Klein J, et al. Exercise‐induced silent ischemia: Age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol 1989;14: 1175–1180. [DOI] [PubMed] [Google Scholar]
  • 9. Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988;62:661–664. [DOI] [PubMed] [Google Scholar]
  • 10. Ruberman W, Crow R, Rosenberg CR, et al. Intermittent ST depression and mortality after myocardial infarction. Circulation. 1992;85: 1440–1446. [DOI] [PubMed] [Google Scholar]
  • 11. Rocco MB, Nabel EG, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988;78:877–884. [DOI] [PubMed] [Google Scholar]
  • 12. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;812:748. [DOI] [PubMed] [Google Scholar]
  • 13. Madjlessi‐Simon T, Mary‐Krause M, Fillette F, et al. Persistent transient myocardial ischemia despite beta‐adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol. 1996;27: 1586–1591. [DOI] [PubMed] [Google Scholar]
  • 14. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two‐year follow‐up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037–2043. [DOI] [PubMed] [Google Scholar]
  • 15. Killip T. Silent myocardial infarction: Some good news. Circulation 1997;95:1992–1993. [DOI] [PubMed] [Google Scholar]
  • 16. Raby KE, Goldman L, Creager MA, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 1989;321:1296–1300. [DOI] [PubMed] [Google Scholar]
  • 17. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high‐risk patients after vascular surgery. Anesth Analg 1999;88:477–482. [DOI] [PubMed] [Google Scholar]
  • 18. Gill JB, Cairns JA, Roberts RS, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996;334:65–70. [DOI] [PubMed] [Google Scholar]
  • 19. Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214–1249. [DOI] [PubMed] [Google Scholar]
  • 20. Nademanne K, Intarachot V, Josephson MA, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987;10:1–9. [DOI] [PubMed] [Google Scholar]
  • 21. Gottlieb SO, Gottlieb SH, Baumgardner R, et al. Silent myocardial ischemia on Holter monitoring predicts mortality in high‐risk postinfarction patients. JAMA 1988;259: 1030–1035. [PubMed] [Google Scholar]
  • 22. Narins DR, Zareba W, Moss AJ, et al. Clinical implications of silent versus symptomatic exercise‐induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol 1997;29:756–763. [DOI] [PubMed] [Google Scholar]
  • 23. Larsson H, Jonasson T, Ringqvist I, et al. Diagnostic and prognostic importance of ST recording after an episode of unstable angina or non‐Q‐wave myocardial infarction. Eur Heart J 1992;13:207–212. [DOI] [PubMed] [Google Scholar]
  • 24. Stone PH, Thompson B, Zaret BL, et al. Factors associated with failure of medical therapy in patients with unstable angina and non‐Q wave myocardial infarction. A TIMI‐IIIB database study. Eur Heart J 1999;20: 1084–1093. [DOI] [PubMed] [Google Scholar]
  • 25. Yeghiazarians Y, Braunstein JB, Askari A, et al. Unstable angina pectoris. N Engl J Med 2000;342:101–114. [DOI] [PubMed] [Google Scholar]
  • 26. Tzivoni D, Benhorin J, Gavish A, et al. Holter recording during treadmill testing in assessing myocardial ischemic changes. Am J Cardiol 1985;55:1200–1203. [DOI] [PubMed] [Google Scholar]
  • 27. Samniah N, Tzivoni D. Assessment of ischemic changes by ambulatory ECG monitoring. J Electrocardiol 1997;30:197–204. [DOI] [PubMed] [Google Scholar]
  • 28. Stone PH, Chaitman BR, McMahon RP, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise‐induced and ambulatory ischemia in patients with stable coronary disease. Circulation. 1996;94: 1537–1544. [DOI] [PubMed] [Google Scholar]
  • 29. Benhorin J, Moriel M, Gavish A, et al. Usefulness of severity of myocardial ischemia on exercise testing in predicting the severity of myocardial ischemia during daily activities. Am J Cardiol 1991;68:176–180. [DOI] [PubMed] [Google Scholar]
  • 30. Banai S, Moriel M, Benhorin J, et al. Changes in myocardial ischemic threshold during daily activities. Am J Cardiol 1990;66:1403–1406. [DOI] [PubMed] [Google Scholar]
  • 31. Benhorin J, Pinsker G, Moriel M, et al. Ischemic threshold during two exercise testing protocols and during ambulatory electrocardiographic monitoring. J Am Coll Cardiol 1993;22:671–677. [DOI] [PubMed] [Google Scholar]
  • 32. Tzivoni D, Medina A, David D, et al. Comparison between Metoprolol orally osmotic once daily and Metoprolol two or three times daily in suppressing exercise induced and daily myocardial ischemia. Am J Cardiol 1996;78:1362–1368. [DOI] [PubMed] [Google Scholar]
  • 33. TIBET study group. Total ischaemic burden European trial (TIBET): Effect of treatment on exercise and Holter ECG in angina. Circulation 1992;86:I–713. [Google Scholar]
  • 34. von Arnim T for the TIBBS investigators. Medical treatment to reduce total ischemic burden: Total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. J Am Coll Cardiol 1995;25:231–238. [DOI] [PubMed] [Google Scholar]
  • 35. Davies RF, Habibi H, Klinke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol. 1995;25: 619–625. [DOI] [PubMed] [Google Scholar]
  • 36. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study. Circulation 1994;90: 762–768. [DOI] [PubMed] [Google Scholar]
  • 37. Theroux P, Baird M, Juneau M, et al. Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise. Circulation 1991;84:15–22. [DOI] [PubMed] [Google Scholar]
  • 38. Tzivoni D, Kadr H, Braat S, et al. Efficacy of mibefrada in comparison with amlodipine in suppressing exercise‐induced and daily silent ischemia: Results of a multicenter, placebo‐controlled trial. Circulation 1997;96:2557–2564. [DOI] [PubMed] [Google Scholar]
  • 39. Andrews TC, Fenton T, Toyosaki N, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti‐ischemic medication. The Angina and SMI Study Group (ASIS). Circulation 1993;88: 92–100. [DOI] [PubMed] [Google Scholar]
  • 40. Deedwania PC. Anti‐ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group. Am J Cardiol 1999;83:1117–1119, A8–9. [DOI] [PubMed] [Google Scholar]
  • 41. Pepine CJ, Feldman RL, Ludbrook P, et al. Left ventricular dyskinesia reversed by intravenous nitroglycerin: A manifestation of silent myocardial ischemia. Am J Cardiol 1986;58:38B–42B. [DOI] [PubMed] [Google Scholar]
  • 42. Pepine CJ, Lopez LM, Bell DM, et al. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: Results of the second transdermal intermittent dosing evaluation study (TIDES‐II). J Am Coll Cardiol. 1997;30: 955–961. [DOI] [PubMed] [Google Scholar]
  • 43. Knuuti MJ, Wahl M, Wiklund I, et al. Acute and long‐term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina. Am J Cardiol 1992;69:1525–1532. [DOI] [PubMed] [Google Scholar]
  • 44. Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation, of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. Eur Heart J 1999;20: 51–57. [DOI] [PubMed] [Google Scholar]
  • 45. Stone PH, Chaitman BR, Forman S, et al. Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (The Asymptomatic Cardiac Ischemia Pilot (ACIP] Study). Am J Cardiol 1997;80:1395–1401. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES